| Trial ID: | L2218 |
| Source ID: | NCT01052025
|
| Associated Drug: |
Curcumin
|
| Title: |
Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Pre-diabetes|Insulin Resistance|Cardiovascular Risk
|
| Interventions: |
DRUG: Curcumin
|
| Outcome Measures: |
Primary: To examine the efficacy of curcumin on the delay of degenerative beta-cells in pancrease for protection of Type 2 Diabetes in patients with impaired glucose tolerance (Pre-diabetes), 12 months | Secondary: To examine the efficacy of curcumin on the reduction of blood sugar level, lipid profile, insulin resistance status and oxidative stress status in Pre-diabetes patients, 12 months
|
| Sponsor/Collaborators: |
Sponsor: Srinakharinwirot University | Collaborators: Ministry of Health, Thailand
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2009-08
|
| Completion Date: |
2010-04
|
| Results First Posted: |
|
| Last Update Posted: |
2010-01-20
|
| Locations: |
HRH Princess Maha Chakri Sirindhorn Medical Center, Ongkarak, Nakornnayok, 26120, Thailand
|
| URL: |
https://clinicaltrials.gov/show/NCT01052025
|
